Skip to Content

WPI 839 (Bupropion Hydrochloride Extended-Release (SR) 150 mg)

Pill with imprint WPI 839 is White, Round and has been identified as Bupropion Hydrochloride Extended-Release (SR) 150 mg. It is supplied by Watson Pharmaceuticals.

Bupropion is used in the treatment of major depressive disorder; depression; anxiety; seasonal affective disorder; adhd (and more), and belongs to the drug classes miscellaneous antidepressants, smoking cessation agents. Risk cannot be ruled out during pregnancy. Bupropion 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 839

Bupropion hydrochloride extended-release (SR) 150 mg WPI 839
Bupropion hydrochloride extended-release (SR) 150 mg WPI 839
Bupropion hydrochloride extended-release (SR) 150 mg WPI 839
Bupropion hydrochloride extended-release (SR) 150 mg WPI 839  Front
Bupropion hydrochloride extended-release (SR) 150 mg WPI 839  Back
Bupropion hydrochloride extended-release (SR) 150 mg WPI 839

Bupropion Hydrochloride Extended-Release (SR)

Imprint:
WPI 839
Strength:
150 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous antidepressants
Smoking cessation agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide